Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy

Abstract

These results suggest that for patients with recent-onset dilated cardiomyopathy, IVIG does not augment the improvement in LVEF. However, in this overall cohort, LVEF improved significantly during follow-up, and the short-term prognosis remains favorable.